Safety of a Cardiac Resynchronization Therapy Device Implantation in a Patient with Unstable Heart Failure Who Require Impella-Device Assistance

Int Heart J. 2022 May 31;63(3):623-626. doi: 10.1536/ihj.21-616. Epub 2022 May 14.

Abstract

Implantation of a cardiac resynchronization therapy (CRT) device is usually scheduled in the compensated phase of heart failure; however, procedural safety may be sometimes disturbed in the decompensated phase. We report a case of a successful semi-urgent implantation of a CRT device temporary assisted with Impella in a patient with the decompensated phase of severe heart failure dependent on inotropic agents and who cannot maintain the supine position. Impella assistance with left ventricular (LV) unloading and maintenance of end-organ perfusion contributed to early recovery from acute heart failure. Furthermore, an acute effect of mechanical resynchronization by biventricular pacing plays an important role in weaning from the mechanical support or inotropic dependence. These mutual effects of mechanical support and CRT might contribute to a decrease in LV end-diastolic pressure and to a remarkable early recovery from a severely decompensated condition.

Keywords: Acute pulmonary edema; Biventricular pacing; LV dyssynchrony; LV unloading; Percutaneous mechanical circulatory support.

Publication types

  • Case Reports

MeSH terms

  • Cardiac Resynchronization Therapy Devices
  • Cardiac Resynchronization Therapy*
  • Heart Failure* / complications
  • Heart Failure* / therapy
  • Heart Ventricles
  • Humans
  • Treatment Outcome